
TI Pipra 4000mg/500mg Injection
Marketer
Triglobal Lifesciences Private Limited
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview TI Pipra 4000mg/500mg Injection
Pipra 4000mg/500mg Injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, the dosage and frequency are determined by your physician based on your condition's severity. Strict adherence to prescribed usage is vital. Potential side effects include nausea, vomiting, diarrhea, and rashes, alongside possible injection site reactions like pain, swelling, or redness. Persistent or worsening side effects necessitate immediate medical consultation. Prior to use, disclose any antibiotic allergies or existing kidney/liver conditions to your doctor, who may adjust the dosage or alternative treatment. While generally safe under medical guidance, its use during pregnancy and breastfeeding requires professional oversight.
Uses of TI Pipra 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of TI Pipra 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of TI Pipra 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use TI Pipra 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How TI Pipra 4000mg/500mg Injection works:
TI Pipra 4000mg/500mg Injection combines Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial survival. Tazobactum counters bacterial resistance, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and TI Pipra 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication TI Pipra (4000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
TI Pipra 4000mg/500mg Injection presents minimal breastfeeding risk. Research in humans indicates negligible transfer to breast milk, posing no identified harm to infants.
DrivingCONSULT YOUR DOCTOR
The effect of TI Pipra 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if any symptoms impair concentration or reaction time.
KidneyCAUTION
Exercise caution when administering the 4000mg/500mg TI Pipra Injection to individuals with impaired renal function. Dosage modification of TI Pipra 4000mg/500mg Injection may be necessary. Seek medical advice.
LiverSAFE IF PRESCRIBED
The use of TI Pipra 4000mg/500mg Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification for this medication might be unnecessary in such cases. However, medical advice should always be sought.
What if you forget to take TI Pipra 4000mg/500mg Injection :
Omit a dose of TI Pipra 4000mg/500mg Injection? Seek your physician's advice.
Facts to Know About TI Pipra 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Anti-infective medications |
